Market News AIOpen the app

Analysts Update Ratings and Price Targets for CG Oncology

OpinionRead the original at marketscreener.com
Good for CGON

All 3 analysts raised their price targets, and 2 kept Buy or Outperform ratings. RBC cut its rating to Sector Perform, but raised its target too, so the analyst news leans favorable.

CGON · CG Oncology, Inc.

AI read · Good for CGON

The AI's read

The higher targets suggest analysts see more room for CG Oncology's shares to rise. RBC's cut to Sector Perform is a caution, but it also raised its target. All 3 firms raised targets, and 2 kept positive ratings, so the changes lean favorable.

Get alerts for CGON

Follow CG Oncology, Inc. (CGON) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for CGON
Free on the App Store and Google Play, or on the web.